Effect of Bronchoalveolar Lavage Fluid from Pneumocystis carinii-Infected Hosts on Phagocytic Activity of Alveolar Macrophages

Infection and Immunity

Volumn 72, Issue 4, 2004, Pages 2140-2147

  Lasbury, Mark E ^a   Lin, Peimao ^a   Tschang, Dennis ^a   Durant, Pamela J ^a   Lee, Chao Hung ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dept of Pathol and Lab Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; BACTERIAL PROTEIN; CONCANAVALIN A; GLYCOPROTEIN; LIPID; MANNOSE; PAPAIN; PEPSIN A; PROTEINASE; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; FEMALE; FILTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; NONHUMAN; PHAGOCYTOSIS; PNEUMOCYSTOSIS; POROSITY; PRIORITY JOURNAL; RAT; TOXOPLASMA GONDII;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FUNGAL PROTEINS; MACROPHAGES, ALVEOLAR; MEMBRANE GLYCOPROTEINS; PHAGOCYTOSIS; PNEUMOCYSTIS CARINII; PNEUMONIA; PNEUMONIA, PNEUMOCYSTIS; RATS; RATS, SPRAGUE-DAWLEY; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 1842484121     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.4.2140-2147.2004     Document Type: Article

References (56)

1. Bartlett, M. S., J. A. Fishman, M. M. Durkin, S. F. Queener, and J. W. Smith. 1988. A new rat model of Pneumocystis carinii infection. J. Clin. Microbiol. 26:1100-1102.
2. Benfield, T. L., B. Lundgren J. H. Shelhammer, and J. D. Lundgren. 1999. Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line. Eur. J. Clin. Investig. 29:717-722.
3. Carlos, I. Z., D. B. Sgarbi, G. C. Santos, and M. C. Placeres. 2003. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand. J. Immunol. 57:214-220.
4. Castro, M., T. I. Morgenthaler, O. A. Hoffman, J. E. Standing, M. S. Rohrbach, and A. H. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:73-81.
5. Celli, J., M. Olivier, and B. B. Finlay. 2001. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 20:1245-1258.
6. Chen, W., E. A. Havel, F. Gigliotti, and A. G. Harmsen. 1993. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance to an inflammatory response. Infect. Immun. 61:97-102.
7. Chen, W., E. A. Havel, L. L. Moldawer, K. W. McIntyre, and A. G. Harmsen. 1992. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J. Exp. Med. 176:713-718.
8. Chen, W., J. W. Mills, and A. G. Harmsen. 1992. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int. J. Exp. Pathol. 73:709-720.
9. Chin, K. S., S. Merali, M. M. Shaw, M. S. Bartlett, and A. B. Clarkson, Jr. 1996. Subpopulations of Pneumocystis carinii separated by a percoll gradient. J. Eukaryot. Microbiol. 34:53s.
10. Ezekowitz, R. A. B., D. J. Williams, H. Koziel, M. Y. K. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155-158.
11. Fleury, J., E. Escudier, M.-J. Pochelle, C. Carre, and J. F. Bernaudin. 1985. Cell population obtained by bronchoalveolar lavage in Pneumocystis carinii pneumonitis. Acta Cytol. 29:721-728.
12. Fraser, I. P., K. Takahashi, H. Koziel, B. Fardin, A. Harmsen, and R. A. Ezekowitz. 2000. Pneumocystis carinii enhances soluble mannose receptor production by macrophages. Microbes Infect. 2:1305-1310.
13. Frevert, C. W., A. E. Warner, E. Weller, and J. D. Brain. 1998. The effect of endotoxin on in vivo rat alveolar macrophage phagocytosis. Exp. Lung Res. 24:745-758.
14. Garvy, B. A., R. A. Ezekowitz, and A. G. Harmsen. 1997. Role of gamma interferon in the host immune response and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65:373-379.
15. Gigliotti, F. 1991. Antigenic variation of a major surface glycoprotein of Pneumocystis carinii. J. Protozool. 38:4-5.
16. Gigliotti, F., and W. T. Hughes. 1988. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Investig. 81:1666-1668.
17. Hidalgo, H. A., R. J. Helmke, V. F. German, and J. A. Mangos. 1992. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60:1-7.
18. Hoffman, O. A., J. E. Standing, and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 150:3932-3940.
19. Holt, P. G. 1986. Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. Clin. Exp. Immunol. 63:261-270.
20. Holt, P. G., J. Oliver, N. Bilyk, C. McMenamin, P. G. McMenamin, G. Kraal, and T. Thepen. 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397-407.
21. Kaneshiro, E. S., and R. G. Sleight. 1994. Biochemistry and metabolism. Lung Biol. Health Dis. 69:45-71.
22. Kobzik, L. 1995. Lung macrophage uptake of unopsonized environmental particles. Role of scavenger-type receptors. J. Immunol. 15:4225-4231.
23. Kolls, J. K., J. M. Beck, S. Nelson, W. R. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am. J. Respir. Cell Mol. Biol. 8:370-376.
24. Koziel, H., Q. Eichbaum, B. A. Kruskal, P. Pinkston, R. A. Rogers, M. Y. Armstrong, F. F. Richards, R. M. Rose, and R. A. Ezekowitz. 1998. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor down regulation. J. Clin. Investig. 102:1332-1344.
25. Krishnan, V. L., A. Meager, D. M. Mitchell, and A. J. Pinching. 1990. Alveolar macrophages in AIDS patients: increased spontaneous tumor necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin. Exp. Immunol. 80:156-160.
26. Lasbury, M. E., P. J. Durant, and C. H. Lee. 2003. Correlation of Pneumocystis carinii burden and alveolar macrophage number during infection and recovery. Clin. Diagn. Lab. Immunol. 10:293-302.
27. Lasbury, M. E., X. Tang, P. J. Durant, and C. H. Lee. 2003. Effect of the transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect. Immun. 71:4943-4952.
28. Lee, H. S., H. J. Shin, M. S. La, and K. Im. 1994. The effect of silica on the development of experimental Acanthamoeba meningoencephalitis with reference to the macrophage role in mice. Korean J. Parasitol. 32:259-266.
29. Lei, B., F. R. DeLeo, N. P. Hoe, M. R. Graham, S. M. Mackie, R. L. Cole, M. Liu, H. R. Hill, D. E. Low, M. J. Federle, J. R. Scott, and J. M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-1305.
30. Limper, A. H. 1998. Alveolar macrophage and glycoprotein responses to Pneumocystis carinii. Semin. Respir. Infect. 13:339-347.
31. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Investig. 99:2110-2117.
32. Linke, M. J., and P. D. Walzer. 1991. Identification and purification of a soluble species of gp120 released by zymolyase treatment of Pneumocystis carinii. J. Protozool. 38:176-178.
33. Liu, L., R. P. Tewari, and P. R. Williamson. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:6034-6039.
34. Mandujano, J. F., N. B. D'Souza, S. Nelson, W. R. Summer, R. C. Beckerman, and J. E. Shellito. 1995. Granulocyte-macrophage colony stimulating factor in Pneumocystis carinii pneumonia in mice. Am. J. Respir. Crit. Care Med. 151:1233-1238.
35. Nakamoto, A., and K. Kitsukawa. 1992. Human lymphocyte proliferative response and gamma-interferon production to Pneumocystis carinii antigen. J. Jpn. Assoc. Infect. Dis. 66:1651-1659.
36. Nakamura, Y., T. Mural, and Y. Ogawa. 1996. Effect of in vitro and in vivo administration of dexamethasone on rat macrophage functions: comparison between alveolar and peritoneal macrophages. Eur. Respir. J. 9:301-306.
37. Neese, L. W., J. E. Standing, E. J. Olson, M. Castro, and A. H. Limper. 1994. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. J. Immunol. 152:4549-4556.
38. Nelson, D., D. Strickland, and P. G. Holt. 1990. Selective attrition of non-recirculating T cells during normal passage through the lung vascular bed. Immunology 69:476-481.
39. O'Riordan, D. M., J. E. Standing, K. Y. Kwon, D. Chang, E. C. Crouch, and A. H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Investig. 95:2699-2710.
40. Paine, R., III, A. M. Preston, S. Wilcoxen, H. Jin, B. B. Siu, S. B. Morris, J. A. Reed, G. Ross, J. A. Whitsett, and J. M. Beck. 2000. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J. Immunol. 164:2602-2609.
41. Palecanda, A., J. Paulauskis, E. Al-Mutairi, A. Imrich, G. Qin, H. Suzuki, T. Kodama, K. Tryggvason, H. Koziel, and L. Kobzik. 1999. Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J. Exp. Med. 189:1497-1506.
42. Paulsrud, J. R., and S. F. Queener. 1994. Incorporation of fatty acids and amino acids by cultured Pneumocystis carinii. J. Eukaryot. Microbiol. 41:633-638.
43. Phelps, D., and R. M. Rose. 1991. Increased recovery of surfactant protein-A in AIDS-related pneumonia. Am. Rev. Respir. Dis. 143:1072-1075.
44. Pottratz, S. T., and W. J. Martin II. 1990. Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J. Clin. Investig. 85:351-356.
45. Pottratz, S. T., J. Paulsrud, J. S. Smith, and W. J. Martin II. 1991. Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp120, a fibronectin binding protein. J. Clin. Investig. 88:403-407.
46. 2 in experimental Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 134:526-531.
47. Stehle, S. E., R. A. Rogers, A. G. Harmsen, and R. A. Ezekowitz. 2000. A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro. Scand. J. Immunol. 52:131-137.
48. Su, T. H., V. Natarajan, and W. J. Martin II. 1992. Pulmonary surfactant in Pneumocystis carinii pneumonia is associated with a marked increase in sphingomyelin. Am. Rev. Respir. Dis. 145:A246.
49. Tang, X., M. E. Lasbury, D. D. Davidson, M. S. Bartlett, J. W. Smith, and C. H. Lee. 2000. Down-regulation of GATA-2 transcription factor during Pneumocystis carinii infection. Infect. Immun. 68:4720-4724.
50. Vassallo, R., J. E. Standing, and A. H. Limper. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164:3755-3763.
51. Warschkau, H., H. Yu, and A. F. Kiderlen. 1998. Activation and suppression of natural cellular immune functions by Pneumocystis carinii. Immunobiology 198:343-360.
52. Weinberg, G. A., C. C. Dykstra, P. J. Durant, and M. T. Cushion. 1994. Chromsomal localization of 20 genes to five distinct pulsed field gel karyotypic forms of rat Pneumocystis carinii. J. Eukaryot. Microbiol. 41:117-118.
53. Young, J. A., J. W. Stone, R. J. S. McGonigle, A. Adu, and J. Michael. 1986. Diagnosing Pneumocystis carinii pneumonia by cytological examination of bronchoalveolar lavage fluid: a report of 15 cases. J. Clin. Pathol. 39:945-949.
54. Yu, M. L., and A. H. Limper. 1997. Pneumocystis carinii induces ICAM-I expression in lung epithelium cells through a TNF-α-mediated mechanism. Am. J. Physiol. 273:L1103-L1111.
55. Yung, K. R., Jr., J. A. Rankin, G. P. Naegel, E. S. Paul, and H. Y. Reynolds. 1985. Bronchoalveolar lavage cells and proteins in patients with acquired immunodeficiency syndrome. Ann. Intern. Med. 103:522-553.
56. Zimmerman, P. E., D. R. Volker, F. X. McCormick, J. R. Paulsrud, and W. J. Martin II. 1992. 120-kd surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein-A. J. Clin. Investig. 89:143-149.